LUM and breast cancer: It was found that OV patients with elevated LUM levels were not sensitive to chemotherapy, while breast cancer, colorectal cancer and GBM patients with elevated LUM levels had greater chemotherapeutic benefits, relative to those with low expressions (Figure 7B).